Suppr超能文献

大肠杆菌K-12 uvrB/recA DNA修复宿主介导试验的评估。II. 在小鼠中对36种化合物的体内试验结果。

An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. II. In vivo results for 36 compounds tested in the mouse.

作者信息

Hellmér L, Bolcsfoldi G

机构信息

AB Astra, Safety Assessment, Södertälje, Sweden.

出版信息

Mutat Res. 1992 Oct;272(2):161-73. doi: 10.1016/0165-1161(92)90044-m.

Abstract

The aim of this study was to further evaluate the E. coli K-12 DNA repair host-mediated assay, as a short-term in vivo genotoxicity test, to be used as a complement to the micronucleus test in the routine testing of chemicals and drugs. The assay involves the administration of the test substance to mice by the route of choice, followed by the intravenous administration of a mixture of DNA repair deficient and proficient derivatives of E. coli K-12. After an incubation period the relative survival of the two strains was determined in blood, liver, lungs, kidneys and testes of the host. A significant preferential reduction of the DNA repair deficient strain in any organ indicates that the test substance possesses genotoxic properties. A total of 36 substances, 26 carcinogens, 4 weak or non-carcinogens and 6 unclassified substances, were tested in this assay. Positive results were obtained for 23 compounds. Of the carcinogens 18 were positive and of the non-carcinogens 3 were negative. The overall concordance between the assay and carcinogenicity was 72%. In general, alkylating agents and direct-acting nitroso compounds showed genotoxic activity in all organs tested, while the other substances were positive in a limited number of organs. With oral administration, which was the most commonly used administration route in the study, the organ showing a positive response most often was the blood. The results from the present study were compared with results from the micronucleus test, which were available for 26 of the substances. Results were in agreement for 15 of the substances, while 8 substances were positive in the present assay and negative in the micronucleus test: 4-aminobiphenyl, 2-anisidine, epichlorohydrin, formaldehyde, 1- and 2-naphthylamine, 2-nitrophenylenediamine and 4-nitroquinoline-N-oxide. The substances negative in the E. coli DNA repair host-mediated assay, but positive in the micronucleus test were: benzene, catechol and cyclophosphamide. It is concluded from this evaluation that the E. coli K-12 DNA repair host-mediated assay detects a number of carcinogens that are negative in the micronucleus test, while detecting most of the compounds that are positive in the latter. The advantages of this test are that differential DNA repair measures a broad spectrum of genetic damage, an in vitro/in vivo comparison is possible with the same test organisms, results can be obtained from various organs and the test is rapid.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

本研究的目的是进一步评估大肠杆菌K-12 DNA修复宿主介导试验,作为一种短期体内遗传毒性试验,用于在化学品和药物的常规检测中补充微核试验。该试验包括通过选择的途径将受试物质给予小鼠,随后静脉注射大肠杆菌K-12的DNA修复缺陷型和 proficient衍生物的混合物。在孵育期后,在宿主的血液、肝脏、肺、肾脏和睾丸中测定两种菌株的相对存活率。任何器官中DNA修复缺陷型菌株的显著优先减少表明受试物质具有遗传毒性特性。在该试验中总共测试了36种物质,26种致癌物、4种弱致癌物或非致癌物以及6种未分类物质。23种化合物获得了阳性结果。在致癌物中,18种呈阳性,在非致癌物中,3种呈阴性。该试验与致癌性之间的总体一致性为72%。一般来说,烷基化剂和直接作用的亚硝基化合物在所有测试器官中均显示出遗传毒性活性,而其他物质仅在有限数量的器官中呈阳性。口服给药是本研究中最常用的给药途径,最常显示阳性反应的器官是血液。将本研究的结果与微核试验的结果进行了比较,其中26种物质有微核试验结果。15种物质的结果一致,而8种物质在本试验中呈阳性,在微核试验中呈阴性:4-氨基联苯、2-甲氧基苯胺、环氧氯丙烷、甲醛、1-和2-萘胺、2-硝基苯二胺和4-硝基喹啉-N-氧化物。在大肠杆菌DNA修复宿主介导试验中呈阴性但在微核试验中呈阳性的物质是:苯、儿茶酚和环磷酰胺。从该评估得出的结论是,大肠杆菌K-12 DNA修复宿主介导试验检测到一些在微核试验中呈阴性的致癌物,同时检测到大多数在微核试验中呈阳性的化合物。该试验的优点是,差异DNA修复可测量广泛的遗传损伤,可使用相同的试验生物进行体外/体内比较,可从各种器官获得结果,并且试验快速。(摘要截断于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验